Jubilant HollisterStier CMO is making significant strides in expanding its capabilities to meet global demand for complex formulations and sterile injectables. In this interview with Contract Pharma, CEO Chris Preti shares insights into the company’s ongoing expansion, its strategic approach to scalability, and its commitment to maintaining the highest standards of quality and compliance. With a history of innovation and adaptability, JHS is poised to address both current challenges and future opportunities in the pharmaceutical manufacturing industry.